A Techno-Legal Study on Current IPR Scenario for Commercialization of Biosimilars in the USA. Journal of Intellectual Property Rights (JIPR), [S. l.], v. 30, n. 3, p. 349–360, 2025. DOI: 10.56042/jipr.v30i3.8221. Disponível em: https://or.niscpr.res.in/index.php/JIPR/article/view/8221. Acesso em: 13 may. 2026.